SCYNEXIS Statistics
Total Valuation
SCYNEXIS has a market cap or net worth of $38.41 million. The enterprise value is -$338,381.
Important Dates
The last earnings date was Wednesday, March 4, 2026, after market close.
| Earnings Date | Mar 4, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
SCYNEXIS has 44.66 million shares outstanding. The number of shares has increased by 2.93% in one year.
| Current Share Class | 41.97M |
| Shares Outstanding | 44.66M |
| Shares Change (YoY) | +2.93% |
| Shares Change (QoQ) | +1.49% |
| Owned by Insiders (%) | 2.26% |
| Owned by Institutions (%) | 23.52% |
| Float | 35.28M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.82 |
| Forward PS | 4.26 |
| PB Ratio | 0.71 |
| P/TBV Ratio | 0.76 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 7.04, with a Debt / Equity ratio of 0.04.
| Current Ratio | 7.04 |
| Quick Ratio | 6.98 |
| Debt / Equity | 0.04 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -33.14 |
Financial Efficiency
Return on equity (ROE) is -16.48% and return on invested capital (ROIC) is -261.24%.
| Return on Equity (ROE) | -16.48% |
| Return on Assets (ROA) | -13.42% |
| Return on Invested Capital (ROIC) | -261.24% |
| Return on Capital Employed (ROCE) | -30.16% |
| Weighted Average Cost of Capital (WACC) | 11.87% |
| Revenue Per Employee | $735,750 |
| Profits Per Employee | -$307,464 |
| Employee Count | 28 |
| Asset Turnover | 0.28 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -11.13% in the last 52 weeks. The beta is 1.32, so SCYNEXIS's price volatility has been higher than the market average.
| Beta (5Y) | 1.32 |
| 52-Week Price Change | -11.13% |
| 50-Day Moving Average | 0.72 |
| 200-Day Moving Average | 0.76 |
| Relative Strength Index (RSI) | 65.01 |
| Average Volume (20 Days) | 385,387 |
Short Selling Information
The latest short interest is 1.12 million, so 2.50% of the outstanding shares have been sold short.
| Short Interest | 1.12M |
| Short Previous Month | 1.13M |
| Short % of Shares Out | 2.50% |
| Short % of Float | 3.16% |
| Short Ratio (days to cover) | 2.17 |
Income Statement
In the last 12 months, SCYNEXIS had revenue of $20.60 million and -$8.61 million in losses. Loss per share was -$0.17.
| Revenue | 20.60M |
| Gross Profit | 20.60M |
| Operating Income | -16.07M |
| Pretax Income | -8.61M |
| Net Income | -8.61M |
| EBITDA | n/a |
| EBIT | -16.07M |
| Loss Per Share | -$0.17 |
Full Income StatementBalance Sheet
The company has $40.03 million in cash and $2.18 million in debt, with a net cash position of $37.86 million or $0.85 per share.
| Cash & Cash Equivalents | 40.03M |
| Total Debt | 2.18M |
| Net Cash | 37.86M |
| Net Cash Per Share | $0.85 |
| Equity (Book Value) | 49.38M |
| Book Value Per Share | 1.13 |
| Working Capital | 34.64M |
Full Balance SheetCash Flow
| Operating Cash Flow | -5.28M |
| Capital Expenditures | n/a |
| Free Cash Flow | -5.28M |
| FCF Per Share | -$0.12 |
Full Cash Flow StatementMargins
Gross margin is 100.00%, with operating and profit margins of -78.03% and -41.79%.
| Gross Margin | 100.00% |
| Operating Margin | -78.03% |
| Pretax Margin | -41.79% |
| Profit Margin | -41.79% |
| EBITDA Margin | n/a |
| EBIT Margin | -78.03% |
| FCF Margin | n/a |
Dividends & Yields
SCYNEXIS does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -2.93% |
| Shareholder Yield | -2.93% |
| Earnings Yield | -22.95% |
| FCF Yield | -14.08% |
Analyst Forecast
The average price target for SCYNEXIS is $3.00, which is 248.84% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $3.00 |
| Price Target Difference | 248.84% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | 48.67% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on July 17, 2020. It was a reverse split with a ratio of 1:10.
| Last Split Date | Jul 17, 2020 |
| Split Type | Reverse |
| Split Ratio | 1:10 |
Scores
SCYNEXIS has an Altman Z-Score of -6.83 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -6.83 |
| Piotroski F-Score | 1 |
